Lv4
408 积分 2023-07-24 加入
As-Needed Albuterol–Budesonide in Mild Asthma
9天前
已完结
Biologic Therapies for Severe Asthma
11天前
已完结
Impact of benralizumab on asthma exacerbation-related medical healthcare resource utilization and medical costs: results from the ZEPHYR 2 study
11天前
已完结
Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2
11天前
已完结
Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study
11天前
已完结
XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma
11天前
已完结
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
11天前
已完结
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
11天前
已完结
Correspondence - Tranexamic acid for traumatic brain injury
11天前
已完结
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
11天前
已完结
皖公网安备34019202002308
